CASP9 and osteosarcoma: Besides, honokiol treatment decreased the S and G2/M populations, increased the number of cells at G0/G1, and honokiol-induced apoptosis in osteosarcoma cells through the mitochondria dysfunction leading to activate caspase-9 and involves a caspase-3-mediated mechanism.